MORGANTOWN, W. VA. – The West Virginia Clinical and Translational Science Institute (WVCTSI) has recently appointed 10 early stage investigators to a new institutional advisory board designed to steer the organization’s practices and policies. Members selected represent WVCTSI strategic partners including the Department of Veterans Affairs, Marshall University (MU), the West Virginia School of Osteopathic Medicine (WVSOM), and West Virginia University (WVU).
- Shinichi Asano, Ph.D., assistant professor of biomedical sciences at WVSOM
- James Bardes, M.D., assistant professor of trauma, acute care surgery, and surgical critical care at the WVU School of Medicine
- Nicole Bryan, M.D., Ph.D., assistant professor with the WVU School of Medicine
- Wei Du, M.D., Ph.D., assistant professor with the WVU School of Pharmacy
- Elizabeth Engler-Chiurazzi, Ph.D., assistant professor with WVU School of Medicine
- Abdul Haji, M.D., chief of cardiology section at the Martinsburg Veterans Affairs Medical Center
- Brandon Henderson, Ph.D., assistant professor with the MU Department of biomedical sciences
- James Mahoney, Ph.D., assistant professor with the WVU Department of behavioral medicine and psychiatry
- Ashley Petrone, Ph.D., assistant professor in the WVU Department of Pathology and Anatomy
- Ankit Sakhuja, M.D., assistant professor in the WVU Department of Cardiovascular and Thoracic Surgery
This group of investigators will provide valuable input to the WVCTSI team regarding the optimization of resources and services to best support early-stage investigators.
“We are very excited to gain invaluable input from this important group of investigators,” said Sally Hodder, M.D., WVCTSI director and associate vice president for clinical and translational science at WVU. “WVCTSI has prioritized facilitating career development of investigators early in their careers as they will drive future advances in biomedical research throughout West Virginia. We are excited to learn from their perspectives and receive their guidance on what they need.”
Advisory board members were selected via a nomination process among WVCTSI partner site leadership. Candidates were selected based on their career research trajectory and previous body of research activity.
“This board has a great spectrum of members that reflect the breadth of clinical and translational research taking place across the Mountain State,” said Julie Lockman, Ph.D., director of investigator development with WVCTSI. “This board includes translational-laboratory scientists, clinical investigators, community/population researchers, and more.”
The board held their first meeting in Spring 2019 and will hold regular meetings over the coming year.
WVCTSI is funded by an IDeA Clinical and Translational grant from the National Institute of General Medical Sciences (5U54GM104942-04) to support the mission of building clinical and translational research infrastructure and capacity to impact health disparities in West Virginia.
Ian Moore, West Virginia Clinical and Translational Science Institute